Improving access to early-phase cancer trials
Increasing Access and Participation to Early Phase Clinical Trials
['FUNDING_OTHER'] · UNIVERSITY OF KANSAS MEDICAL CENTER · NIH-11163214
This project works to make it easier for people with cancer, including veterans, to find and join early-phase clinical trials of new experimental therapies.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF KANSAS MEDICAL CENTER (nih funded) |
| Locations | 1 site (KANSAS CITY, UNITED STATES) |
| Trial ID | NIH-11163214 on ClinicalTrials.gov |
What this research studies
As a patient, you'll see efforts to simplify finding and joining early-phase cancer trials through a roadmap developed at the University of Kansas Cancer Center. The team will analyze unmet needs across their catchment area, speed up trial activation and prioritization within the Experimental Therapeutics Clinical Trials Network (ETCTN), and engage physicians to improve referrals. They'll also streamline genomic testing of tumors so patients with matching biomarkers can be identified faster. The approach builds on lessons from NCI-sponsored trials and focuses on sustainable, clinic-ready changes that include veterans and regional patients.
Who could benefit from this research
Good fit: Ideal candidates are people with cancer in the KU Cancer Center catchment area—including veterans—who may be eligible for early-phase ETCTN trials and can provide tumor samples for genomic testing.
Not a fit: People without cancer, those outside the catchment area without access to participating sites, or patients who are medically ineligible for early-phase trials may not benefit directly.
Why it matters
Potential benefit: If successful, more patients could access promising experimental therapies sooner and be matched to trials that fit their tumor's genetics.
How similar studies have performed: Other centers have improved enrollment using targeted outreach and genomic-matching programs, but applying these strategies specifically to early-phase ETCTN trials is relatively new.
Where this research is happening
KANSAS CITY, UNITED STATES
- UNIVERSITY OF KANSAS MEDICAL CENTER — KANSAS CITY, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BARANDA, JOAQUINA C — UNIVERSITY OF KANSAS MEDICAL CENTER
- Study coordinator: BARANDA, JOAQUINA C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer Center, Cancer Treatment